Tvardi Therapeutics
Price & Volume
Stats
See more52W Range | $2.75-$43.65 |
Market Cap | $29.6M |
Shares Short | 653,882 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.39 |
News
See moreYahoo Finance • 4 months ago
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Yahoo Finance • 4 months ago
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Yahoo Finance • 5 months ago
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Yahoo Finance • 5 months ago
Tvardi Therapeutics GAAP EPS of -$0.59 beats by $0.22
About
CEO | Dr. Imran Alibhai Ph.D. |
Address | 3 Sugar Creek Center Boulevard, Sugar Land, TX, United States, 77478 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
